Farmak reinvests 95% of its profits in the development.
“We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a very large amount of money, but I have no intention to sell them. Basically, I am a rather wealthy person, but I have no special wealth. And I do not need it – I do not like a luxurious life. When I am abroad, I prefer to go and buy food at the market than dine at a fancy restaurant,” said Filya Zhebrovska, Chairman of the Supervisory Board of JSC Farmak in the interview with Focus.
As Filya Zhebrovska explains, the Company now goes through the transition period that will last for another two or three years. “In 2017, before retiring from business, I worked a lot on business processes, and then I invited Slovakian expatriate manager Augustin Dubnička to manage the Company, as I wanted to make sure that the built processes were clear for people from the outside. He worked for nine months and we experienced no catastrophe. After that, I entrusted control to Volodymyr Kostiuk, and since then I have not interfered with the operational activities. All top managers of the Company, with whom we created Farmak, joined me in the Supervisory Board. We have to afford an opportunity to the next generation to prove themselves,” she said.
It is worth noting that Farmak plans to invest approximately UAH 1.2 billion in the development in 2020.
September 29 is World Heart Day. In Ukraine, cardiovascular diseases are the main cause of death among the population. According to this indicator, our country remains one of the world leaders, according to the study of the Global Burden of Disease. In addition, war is a time when a person is constantly in emotional tension […]
Ukrainian business continues to securely hold the economic front and invest in the development of the state even during the war. Pharmaceutical company Farmak recently opened a new nebula drug production site, construction of which began before Russia’s full-scale invasion of Ukraine. Medicines in nebulas are intended for inhalation administration and ...
The contribution of doctors who daily hold the medical front and fight for the lives of Ukrainians around the clock can not be overstated. Expressing gratitude and support to doctors, the pharmaceutical company Farmak allocated 1 million hryvnias to reward doctors who made a special contribution to Ukraine’s fight against the Russian invader. The ̶...